The Chemours Co 2025年季度报告

FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the quarterly period ended March 31, 2025 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 Commission File Number 001-36794 The Chemours Company(Exact Name of Registrant as Specified in Its Charter) 46-4845564(I.R.S. EmployerIdentification No.) Delaware(State or other Jurisdiction ofIncorporation or Organization) 1007 Market Street, Wilmington, Delaware 19801(Address of Principal Executive Offices) Securities registered pursuant to Section 12(b) of the Act: Name of Exchange on Which Registered New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”and “emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated Filer☐Smaller reporting company☐Emerging growth company☐ Large Accelerated Filer☒Non-Accelerated Filer☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒The registrant had 149,674,209 shares of common stock, $0.01 par value, outstanding at May 1, 2025. The Chemours Company Part IFinancial InformationItem 1.Interim Consolidated Financial Statements2Interim Consolidated Statements of Operations (Unaudited)2Interim Consolidated Statements of Comprehensive Income (Unaudited)3Interim Consolidated Balance Sheets (Unaudited)4Interim Consolidated Statements of Stockholders’ Equity (Unaudited)5Interim Consolidated Statements of Cash Flows (Unaudited)6Notes to the Interim Consolidated Financial Statements (Unaudited)7Item 2.Management’s Discussion and Analysis of Financial Condition and Results ofOperations64Item 3.Quantitative and Qualitative Disclosures About Market Risk87Item 4.Controls and Procedures88 Part IIOther InformationItem 1.Legal Proceedings89Item 1A.Risk Factors89Item 2.Unregistered Sales of Equity Securities and Use of Proceeds92Item 3.Defaults Upon Senior Securities92Item 4.Mine Safety Disclosures92Item 5.Other Information92Item 6.Exhibits94Signature95 PART I. FINANCIAL INFORMATION The Chemours CompanyInterim Consolidated Statements of Operations (Unaudited)(Dollars in millions, except per share amounts) See accompanying notes to the interim consolidated financial statements. The Chemours CompanyInterim Consolidated Statements of Comprehensive Income (Unaudited)(Dollars in millions) See accompanying notes to the interim consolidated financial statements. The Chemours CompanyInterim Consolidated Balance Sheets (Unaudited)(Dollars in millions, except per share amounts) March31,2025December 31, 2024AssetsCurrent assets:Cash and cash equivalents$464$713Accounts and notes receivable, net858770Inventories1,5501,463Prepaid expenses and other6171Total current assets2,9333,017Property, plant, and equipment9,6249,572Less: Accumulated depreciation(6,493)(6,389)Property, plant, and equipment, net3,1313,183Operating lease right-of-use assets286258Goodwill4646Other intangible assets, net23Investments in affiliates164152Restricted cash and restricted cash equivalents5050Other assets782804Total assets$7,394$7,513Liabilities See accompanying notes to the interim consolidated financial statements. The Chemours CompanyInterim Consolidated Statements of Cash Flows (Unaudited)(Dollars in millions) Purchases of property, plant, and equipment(84)(102)Proceeds from sales of assets and businesses—3Foreign exchange contract settlements, net(2)(2)Cash used for investing activities(86)(101)Cash flows from financing activitiesDebt repayments(8)(3)Payments on finance leases(3)(3)Proceeds from supplier financing program2727Payments to supplier financing program(35)(37)Proceeds from exercised stock options, net—1Payments related to tax withholdings on vested stock awards(1)(2)Payments of dividends to the Company's common shareho